In vitro IgE inhibition in B cells by anti-CD23 monoclonal antibodies is functionally dependent on the immunoglobulin Fc domain

International Journal of Immunopharmacology

Volumn 22, Issue 2, 2000, Pages 131-141

  Nakamura, Takehiko ^a   Kloetzer, William S ^b   Brams, Peter ^b   Hariharan, Kandasamy ^b   Chamat, Soulaima ^b   Cao, Xianjun ^b   Labarre, Michael J ^b   Chinn, Paul C ^b   Morena, Ron A ^b   Shestowsky, William S ^b   Li, Yan Ping ^b   Chen, Agnes ^b   Reff, Mitchell E ^b  

^a SEIKAGAKU CORPORATION   (Japan)

^b BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR; INTERLEUKIN 4; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CROSS LINKING; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; INHIBITION KINETICS; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FC FRAGMENTS; MACACA FASCICULARIS; RECEPTORS, IGE;

EID: 0033984514     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00068-5     Document Type: Article

References (38)

1. Yokota A., Kikutani H., Tanaka T., Sato R., Barsumian E.L., Suemura M., et al. Two species of human Fce receptor II (FCeRII/CD23): tissue-specific and IL-4-specific regulation of gene expression. Cell. 55:1988;611-618.
2. Yokota A., Yukawa K., Yamamoto A., Sugiyama K., Suemura M., Tashiro Y., et al. Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains. PNAS. 89:1992;5030-5034.
3. Abdelilah S.G., Bouchaib L., Morita M., Delphine A., Marika S., Andre C., et al. Molecular characterization of the low-affinity IgE receptor FceRII/CD23 expressed by human eosinophils. International Immunology. 10:1998;395-404.
4. Delespesse G., Suter U., Mossalayi D., Bettler B., Sarfati M., Hofstetter H., et al. Expression, structure and function of the CD23 antigen. Advances in Immunology. 49:1991;149-189.
5. Becherel P.A., LeGoff L., Frances C., Chosidow O., Guillosson J.J., Debre P., et al. Induction of IL-10 synthesis by human keratinocytes through CD23 ligation: a cyclic adenosine 3′, 5′-monophosphate-dependent mechanism. J. Immunol. 159:1997;5761-5765.
6. Joseph M., Soussi Gounni A., Kusnierz J-P., Vorng H., Sarfati M., Kinet J-P., et al. Expression and functions of the high-affinity IgE receptor on human platelets and megakaryocyte precursors. Eur. J. Immunol. 27:1997;2212-2218.
7. Vercelli D., Helm B., March P., Padlan E., Geha R.S., Gould H. The B-cell binding site on human immunoglobulin E. Nature. 338:1989;649-651.
8. Aubry J-P., Pochon S., Gauchat J-F., Nueda-Marin A., Holers V.M., Graber P., et al. CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21. Journal of Immunology. 152:1994;5806.
9. Lecoanet-Henchoz S., Gauchat J-F., Aubry J-P., Graber P., Life P., Paul-Eugene N., et al. CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18. Immunity. 3:1995;119-125.
10. Gould H.J., Beavil R.L., Relijic R., Shi J., Ma C.W., Sutton B.J., et al. IgE homeostasis: is CD23 the safety switch? Vercelli D. IgE regulation: molecular mechanisms. 1997;37-59 John Wiley.
11. Pene J., Chretien I., Rousset F., Briere F., Bonnefoy J-Y., de Vries J.E. Modulation of IL-4-induced human IgE production in vitro by IFN-g and IL-5: the role of soluble CD23 (s-CD23). Journal of Cellular Biochemistry. 39:1989;253-264.
12. Bartlett W.C., Contad D.H. Murine soluble FceRII: a molecule in search of a function. Res. Immunol. 143:1992;431-436.
13. Armant M., Ishihara H., Rubio M., Delespesse G., Sarfati M. Regulation of cytokine production by soluble CD23: costimulation of interferon g secretion and triggering of tumor necrosis factor a release. J. Exp. Med. 180:1994;1005-1011.
14. Stief A., Texido G., Sansig G., Eibel H., Le Gros G., van der Putten H. Mice deficient in CD23 reveal its modulatory role in IgE production by no role in T and B cell development. Journal of Immunology. 152:1994;3378-3390.
15. Yu P., Kosco-Vilbois M., Richards M., Kohler G., Lamers M.C. Negative feedback regulation of IgE synthesis by murine CD23. Nature. 369:1994;753-756.
16. Fujiwara H., Kikutani H., Suematsu S., Naka T., Yoshida K., Yoshida K., et al. The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. PNAS. 91:1994;6835-6839.
17. Sarfati M., Delespesse G. Possible role of human lymphocyte receptor for IgE (CD23) or its soluble fragments in the in vitro synthesis of human IgE. Journal of Immunology. 141:1988;2195-2199.
18. Bonnefoy J-Y., Shields J., Mermod J-J. Inhibition of human interleukin 4-induced IgE synthesis by a subset of anti-CD23/FceRII monoclonal antibodies. Eur. J. Immunol. 20:1990;139-144.
19. Wakai M., Pasley P., Sthoeger Z.M., Posnett D.N., Brooks R., Hashimoto S., et al. Anti-CD23 monoclonal antibodies: comparisons of epitope specificities and modulating capacities for IgE binding and production. Hybridoma. 12:1993;25-43.
20. Luo H., Hofstetter H., Banchereau J., Delespesse G. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation. Journal of Immunology. 146:1991;2122-2129.
21. Sherr E., Macy E., Kimata H., Gilly M., Saxon A. Binding the low affinity FceR on B cells suppresses ongoing human IgE synthesis. Journal of Immunology. 142:1989;481-489.
22. Saxon A., Kurbe-Leamer M., Behle K., Max E.E., Zhang K. Inhibition of human IgE production via FceR-II stimulation results from a decrease in the mRNA for secreted but not membrane e H chains. Journal of Immunology. 147:11991;4000-4006.
23. i and polyphosphoinositide hydrolysis in human activated B cells. Journal of Immunology. 145:1990;429-437.
24. Kolb J-P., Genot E., Poggioli J., Abadie A., Sarfati M., Delespesse G., et al. Transduction through CD23: different signalling pathways in human B cells and monocytes. Monogr. Allergy. 29:1991;135-155.
25. Kolb J-P., Abadie A., Paul-Eugene N., Capron M., Marie Sarfati M., Dugas B., et al. Ligation of CD23 triggers cyclic AMP generation in human B lymphocytes. Journal of Immunology. 150:1993;4798-4809.
26. Christie G., Barton A., Bolognese B., Buckle D.R., Cook R.M., Hansbury M.J., et al. IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (FceRII). Eur. J. Immunol. 27:1997;3225-3228.
27. Flores-Romo L., Shields J., Humbert Y., Graber P., Aubry J-P., Gauchat J-F., et al. Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. Science. 261:1993;1038-1041.
28. Coyle A.J., Wagner K., Bertrand C., Tsuyuki S., Bews J., Heusser C. Central role of immunoglobulin (Ig) E in the induction of lung eosinophil infiltration and T helper 2 cell cytokine production: inhibition by a non-anaphylatogenic anti-IgE antibody. J. Exp. Med. 183:1996;1303-1310.
29. Carroll W.L., Thielemans K., Dilley J., Levy R. Mouse×human heterohybridomas as fusion partners with human B cell tumors. Journal of Immunological Methods. 89:1986;61-72.
30. Linsley P.S., Brady W., Grosmaire L., Aruffo A., Damle N.K., Ledbetter J.A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:1991;721-730.
31. Wu C.Y., Sarfati M., et al. Glucocorticords increase the synthesis of immunoglobulin E by interleukin 4 stimulated human lymphocytes. J. Clin. Invest. 87:1991;870-877.
32. Newman R., Alberts J., Anderson D., Carner K., Heard C., Norton F., et al. "Primitization" of recombinant antibodies for immunotherapy of human diseases: a macaque/human chimeric antibody against human CD4. BioTechnology. 10:1992;1455-1460.
33. Angal S., King D.J., Bodmer M.W., Turner A., Lawson A.D.G., Roberts G., et al. A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody. Molecular Immunology. 30:1993;105-108.
34. Barnett R.S., Limoli K.L., Huynh T.B., Ople E.A., Reff M.E. Antibody production in Chinese hamster ovary cells using an impaired selectable marker. Imanaka H.Y.WaT. Antibody expression and engineering. 1995;27-40.
35. Urlaub G., Mitchell P.J., Kas E., Chasin L.A., Funanage V.L., Myoda T.T., et al. Effect of gamma rays at the dihydrofolate reductase locus: deletions and inversions. Somatic Cell and Molecular Genetics. 12:1986;555-556.
36. 2. PNAS. 85:1988;6880-6884.
37. Muta T., Kurosaki T., Misulovin Z., Sanchez M., Nussenzweig N.C., Ravetch J.V. A 13-amino-acid motif in the cytoplasmic domain of FcgRIIB modulates B-cell receptor signalling. Nature. 368:1996;70-73.
38. Ashman R.F., Peckham D., Stunz L.L. Fc receptor off-signal in the B cell involves apoptosis. Journal of Immunology. 157:1996;5-11.